Novel Chitosan-based PH-responsive Lipid-polymer Hybrid Nanovesicles (OLA-LPHVs) For Delivery Of Vancomycin Against Methicillin-resistant Staphylococcus Aureus Infections.
Daniel Zumerkorn Hassan, Calvin A. Omolo, Victoria Oluwaseun Fasiku, Chunderika Mocktar, Thirumala Govender
Published 2020 · Chemistry, Medicine
Twitter
Facebook
LinkedIn
Email The development of novel materials is necessary for adequate delivery of drugs to combat the Methicillin-resistant Staphylococcus aureus (MRSA) burden due to the limitations of conventional methods and challenges associated with antimicrobial resistance. Hence, this study aimed to synthesise a novel oleylamine based zwitterionic lipid (OLA) and explore its potential to formulate chitosan-based pH-responsive lipid-polymer hybrid nanovesicles (VM-OLA-LPHVs1) to deliver VM against MRSA. The OLA was synthesised, and the structure characterised by 1H NMR, 13C NMR, FT-IR and HR-MS. The preliminary biocompatibility of OLA and VM-OLA-LPHVs1 was evaluated on HEK-293, A-549, MCF-7 and HepG-2 cell lines using in vitro cytotoxicity assay. The VM-OLA-LPHVs1 were formulated by ionic gelation method and characterised in order to determine the hydrodynamic diameter (DH), morphology in vitro and in vivo antibacterial efficacy. The result of the in vitro cytotoxicity study revealed cell viability of above 75% in all cell lines when exposed to OLA and VM-OLA-LPHVs1, thus indicating their biosafety. The VM-OLA-LPHVs1 had a DH, polydispersity index (PDI), and EE% of 198.0 ± 14.04 nm, 0.137 ± 0.02, and 45.61 ± 0.54% respectively at physiological pH, with surface-charge (ζ) switching from negative at pH 7.4 to positive at pH 6.0. The VM release from the VM-OLA-LPHVs1 was faster at pH 6.0 compared to physiological pH, with 97% release after 72-h. The VM-OLA-LPHVs1 had a lower minimum inhibitory concentration (MIC) value of 0.59 μg/mL at pH 6.0 compared to 2.39 μg/mL at pH 7.4, against MRSA with 52.9-fold antibacterial enhancement. The flow cytometry study revealed that VM-OLA-LPHVs1 had similar bactericidal efficacy on MRSA compared to bare VM, despite an 8-fold lower VM concentration in the nanovesicles. Additionally, fluorescence microscopy study showed the ability of the VM-OLA-LPHVs1 to eliminate biofilms. The electrical conductivity, and protein/DNA concentration, increased and decreased respectively, as compared to bare VM which indicated greater MRSA membrane damage. The in vivo studies in a BALB/c mouse-infected skin model treated with VM-OLA-LPHVs1 revealed 95-fold lower MRSA burden compared to the group treated with bare VM. These findings suggest that OLA can be used as an effective novel material for complexation with biodegradable polymer chitosan (CHs) to form pH-responsive VM-OLA-LPHVs1 nanovesicles which show greater potential for enhancement and improvement of treatment of bacterial infections.
This paper references
10.1016/j.biomaterials.2013.11.046
Core-shell type lipid/rPAA-Chol polymer hybrid nanoparticles for in vivo siRNA delivery.
Lingyan Gao (2014)
10.1016/j.jconrel.2010.01.008
An oral delivery system for indomethicin engineered from cationic lipid emulsions and silica nanoparticles.
Spomenka Simović (2010)
10.3109/10837450.2013.846375
Optimization of particle size and encapsulation efficiency of vancomycin nanoparticles by response surface methodology
Soheyla Honary (2014)
10.1128/9781555816728.CH68
Susceptibility Test Methods: Dilution and Disk Diffusion Methods*
Jean Baldus Patel (2011)
10.1038/s41598-018-33595-5
Induction of the viable but non-culturable state in bacterial pathogens by household cleaners and inorganic salts
Christian Robben (2018)
10.1016/j.polymer.2006.01.073
Preparation, characterization and antimicrobial activity of quaternized carboxymethyl chitosan and application as pulp-cap
Liping Sun (2006)
10.1016/j.carbpol.2015.09.078
Cefazolin loaded chitosan nanoparticles to cure multi drug resistant Gram-negative pathogens.
Bushra Jamil (2016)
10.1016/j.jgar.2014.04.006
Vancomycin-intermediate resistance in Staphylococcus aureus.
Keiichi Hiramatsu (2014)
10.1056/NEJMoa025025
Infection with vancomycin-resistant Staphylococcus aureus containing the vanA resistance gene.
S Chang (2003)
10.1016/j.ijfoodmicro.2008.03.004
The antibacterial properties of a novel chitosan-Ag-nanoparticle composite.
Pallab Sanpui (2008)
10.1016/j.bbamem.2003.11.016
pH gradient loading of anthracyclines into cholesterol-free liposomes: enhancing drug loading rates through use of ethanol
Nancy Ellen Dos Santos (2004)
10.1016/j.chemphyslip.2005.07.004
Production of soybean phosphatidylcholine-chitosan nanovesicles by reverse phase evaporation: a step by step study.
Omar Mertins (2005)
10.18311/AJPRHC/2018/16265
Leadership and Task Shifting to Address the Challenges of Antimicrobial Resistance in South Africa
Kemesha Govender (2018)
10.1016/j.msec.2018.06.037
Catechol-rich gelatin hydrogels in situ hybridizations with silver nanoparticle for enhanced antibacterial activity.
Phuong Le Thi (2018)
10.1016/J.JDDST.2018.02.016
Solid lipid nanoparticles of Vancomycin loaded with Ellagic acid as a tool for overcoming nephrotoxic side effects: Preparation, characterization, and nephrotoxicity evaluation
Hibah M. Aldawsari (2018)
10.1016/J.MATTOD.2013.09.002
Hybrid polymer/lipid vesicles: state of the art and future perspectives
Jean-François Le Meins (2013)
10.1166/JBN.2012.1387
Effects of the composite nanovesicles on the physical properties and cellular adhesion of chitosan films.
Maria Ismenia Zulian Lionzo (2012)
10.1039/C5RA11687B
Systematic development of novel cationic self-nanoemulsifying drug delivery systems of candesartan cilexetil with enhanced biopharmaceutical performance
Gajanand Sharma (2015)
10.1016/j.bbamem.2012.05.012
Antimicrobial selectivity based on zwitterionic lipids and underlying balance of interactions.
Carola I E von Deuster (2012)
10.1021/jf070094x
Interaction of four monoterpenes contained in essential oils with model membranes: implications for their antibacterial activity.
M Cristani (2007)
10.1038/ja.2014.66
Influence of sub-inhibitory antibiotics and flow condition on Staphylococcus aureus ATCC 6538 biofilm development and biofilm growth rate: BioTimer assay as a study model
Francesca Berlutti (2014)
10.1016/j.micinf.2007.12.011
The antibacterial activity against MRSA strains and other bacteria of a <500Da fraction from maggot excretions/secretions of Lucilia sericata (Diptera: Calliphoridae).
Alyson Bexfield (2008)
10.3389/fphar.2017.00374
Asymmetrical Polymer Vesicles for Drug delivery and Other Applications
Yi Zhao (2017)
10.1093/jac/dkn080
Risk factors for nephrotoxicity associated with continuous vancomycin infusion in outpatient parenteral antibiotic therapy.
P. Ingram (2008)
10.1080/02652048.2017.1321047
Exploring the effect of formulation parameters on the particle size of carboxymethyl chitosan nanoparticles prepared via reverse micellar crosslinking
Zeinab Sadat Sheikholeslami (2017)
10.1016/J.SNB.2017.03.079
Vancomycin modified PEGylated-magnetic nanoparticles combined with PCR for efficient enrichment and detection of Listeria monocytogenes
Xiangyu Meng (2017)
10.1371/journal.pone.0151694
A Rapid and Quantitative Flow Cytometry Method for the Analysis of Membrane Disruptive Antimicrobial Activity
Neil M O'Brien-Simpson (2016)
10.1016/j.biomaterials.2017.01.008
Targeting NF-kB signaling with polymeric hybrid micelles that co-deliver siRNA and dexamethasone for arthritis therapy.
Qin Wang (2017)
10.1016/j.colsurfb.2009.08.048
Interaction between phospholipids bilayer and chitosan in liposomes investigated by 31P NMR spectroscopy.
Omar Mertins (2010)
10.4161/viru.2.5.17035
The growing role of nanotechnology in combating infectious disease
Karin Blecher (2011)
10.1016/j.carres.2004.09.007
Preparation and antibacterial activity of chitosan nanoparticles.
Lifeng Qi (2004)
10.1016/j.ijbiomac.2015.12.077
Application of Box-Behnken design for preparation of levofloxacin-loaded stearic acid solid lipid nanoparticles for ocular delivery: Optimization, in vitro release, ocular tolerance, and antibacterial activity.
Mirza Salman Baig (2016)
10.1016/J.PROGPOLYMSCI.2011.06.003
Alginate: properties and biomedical applications.
Kuen Yong Lee (2012)
10.1016/J.APSUSC.2017.12.066
Surfactant mediated interaction of vancomycin with silver nanoparticles
Amritpal Kaur (2017)
10.1016/j.drudis.2008.07.010
Recent approaches for the treatment of periodontitis.
Nilu Jain (2008)
10.1021/acsami.7b09725
Highly Specific Binding on Antifouling Zwitterionic Polymer-Coated Microbeads as Measured by Flow Cytometry
Esther van Andel (2017)
10.22037/IJPR.2012.1191
Statistical Optimization of Oral Vancomycin-Eudragit RS Nanoparticles Using Response Surface Methodology
Badir Delf Loveymi (2012)
10.1016/j.mimet.2012.08.007
Progress in understanding preferential detection of live cells using viability dyes in combination with DNA amplification.
Mariana Fittipaldi (2012)
10.1021/nn4039589
Polymersome shape transformation at the nanoscale.
Romain Salva (2013)
10.1016/j.ejps.2017.12.012
Drug transport mechanisms and in vitro release kinetics of vancomycin encapsulated chitosan‐alginate polyelectrolyte microparticles as a controlled drug delivery system
Janitha M. Unagolla (2018)
10.1021/mp400610b
Polymersome-mediated delivery of combination anticancer therapy to head and neck cancer cells: 2D and 3D in vitro evaluation.
Helen Elizabeth Colley (2014)
10.1016/0022-1759(83)90303-4
Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays.
Timothy R. Mosmann (1983)
10.1016/S0091-679X(08)60989-9
Fluorescence labeling and microscopy of DNA.
Donna J. Arndt-Jovin (1989)
10.1016/j.ijpharm.2018.05.075
Layer‐by‐layer nanocoating of antibacterial niosome on orthopedic implant
Anupma Dwivedi (2018)
10.1016/j.injury.2017.04.012
Review of MRSA screening and antibiotics prophylaxis in orthopaedic trauma patients; The risk of surgical site infection with inadequate antibiotic prophylaxis in patients colonized with MRSA.
Hafiz Javaid Iqbal (2017)
10.1021/acs.molpharmaceut.9b00713
pH-responsive lipid-dendrimer hybrid nanoparticles: An approach to target and eliminate intracellular pathogens.
Ruma Maji (2019)
10.1016/j.diagmicrobio.2017.03.008
Relationship between vancomycin exposure and outcomes among patients with MRSA bloodstream infections with vancomycin Etest® MIC values of 1.5mg/L: A pilot study.
D. M. Martirosov (2017)
10.1021/MZ500748F
Phase Separation and Nanodomain Formation in Hybrid Polymer/Lipid Vesicles
Thi Phuong Tuyen Dao (2015)
10.1016/S0167-7012(03)00025-3
Molecular methods for the assessment of bacterial viability.
Jacquie T. Keer (2003)
10.1248/cpb.52.1117
Study on the stevioside analogues of steviolbioside, steviol, and isosteviol 19-alkyl amide dimers: synthesis and cytotoxic and antibacterial activity.
Lun-Huei Lin (2004)
10.1016/j.ijantimicag.2018.09.018
Antibacterial and antivirulence activities of auranofin against Clostridium difficile.
Ahmed Abdelkhalek (2019)
10.1016/j.ijpharm.2010.08.022
Chitosan as a carrier for targeted delivery of small interfering RNA.
Walter E. Rudzinski (2010)
10.3390/POLYM3031377
Poly Lactic-co-Glycolic Acid (PLGA) as Biodegradable Controlled Drug Delivery Carrier.
Hirenkumar K. Makadia (2011)
10.1039/C7RA12620D
Reduction and pH dual-sensitive nanovesicles co-delivering doxorubicin and gefitinib for effective tumor therapy
Yan-Gui Chen (2018)
10.1111/j.1469-0691.2006.01573.x
The molecular evolution of methicillin-resistant Staphylococcus aureus.
Ruud H. Deurenberg (2007)
10.1016/j.xphs.2017.05.038
Mechanistic Analysis of Human Skin Distribution and Follicular Targeting of Adapalene-Loaded Biodegradable Nanospheres With an Insight Into Hydrogel Matrix Influence, In Vitro Skin Irritation, and In Vivo Tolerability.
Marwa Ahmed Sallam (2017)
10.1016/j.ijpharm.2019.01.010
Delivery of novel vancomycin nanoplexes for combating methicillin resistant Staphylococcus aureus (MRSA) infections
Daniel Zumerkorn Hassan (2019)
10.1016/j.tiv.2004.03.012
Comparison of alamar blue and MTT assays for high through-put screening.
Rabia Hamid (2004)
10.1016/j.jgar.2018.08.017
Changes in resistance to and antimicrobial activity of antibiotics during in vitro human digestion.
Seung Yun Lee (2018)
10.3389/fmicb.2016.01748
Antibacterial Potential of Jatropha curcas Synthesized Silver Nanoparticles against Food Borne Pathogens
Nitin Kumar Chauhan (2016)
10.1007/s00253-011-3502-1
Flocculation in ale brewing strains of Saccharomyces cerevisiae: re-evaluation of the role of cell surface charge and hydrophobicity
Ann Van Holle (2011)
Cell Viability Assays
Terry L. Riss (2016)
10.1186/s13059-017-1252-9
Methicillin-resistant Staphylococcus aureus emerged long before the introduction of methicillin into clinical practice
C P Harkins (2017)
10.1021/la103576a
Quick synthesis of lipid-polymer hybrid nanoparticles with low polydispersity using a single-step sonication method.
Ronnie Hongbo Fang (2010)
10.1166/jnn.2006.521
Structural evaluation of phospholipidic nanovesicles containing small amounts of chitosan.
Omar Mertins (2006)
Stability Testing of Pharmaceutical Products
Sanjay Bajaj (2012)
10.1021/nl503508h
Bacterial protoplast-derived nanovesicles as vaccine delivery system against bacterial infection.
Oh Youn Kim (2015)
10.1016/j.ijantimicag.2005.10.021
Antibacterial activity of liposomal gentamicin against Pseudomonas aeruginosa: a time-kill study.
Gavin Rukholm (2006)
10.1021/CM4000476
Oleylamine in Nanoparticle Synthesis
Stefanos Mourdikoudis (2013)
10.1016/B978-0-323-52725-5.00005-8
Effect of Polymer-Based Nanoparticles on the Assay of Antimicrobial Drug Delivery Systems
Mehmet Gumustas (2017)
10.1080/1385772X.2012.688328
Polymeric micelles: authoritative aspects for drug delivery
Sushant S. Kulthe (2012)
10.1093/jac/dkn329
Predictors of high vancomycin MIC values among patients with methicillin-resistant Staphylococcus aureus bacteraemia.
Thomas P Lodise (2008)
10.2147/IJN.S147226
Anti-MRSA malleable liposomes carrying chloramphenicol for ameliorating hair follicle targeting
Ching-Yun Hsu (2017)
10.1155/2018/6942452
Mechanism of Azalomycin F5a against Methicillin-Resistant Staphylococcus aureus
Li Xin Xu (2018)
10.3109/1061186X.2015.1064435
Preparation and in vivo/in vitro evaluation of formononetin phospholipid/vitamin E TPGS micelles
Xudong Cheng (2016)
10.3390/ijms19041114
Antibacterial Free Fatty Acids and Monoglycerides: Biological Activities, Experimental Testing, and Therapeutic Applications
Bo Kyeong Yoon (2018)
10.1016/j.colsurfb.2009.09.001
Biodegradable polymeric nanoparticles based drug delivery systems.
Avnesh Kumari (2010)
10.3892/ETM.2016.3486
Antibacterial activity of oxyresveratrol against methicillin-resistant Staphylococcus aureus and its mechanism.
Dae-Ki Joung (2016)
10.1016/j.msec.2012.09.001
Oral insulin delivery by self-assembled chitosan nanoparticles: in vitro and in vivo studies in diabetic animal model.
Piyasi Mukhopadhyay (2013)
10.1016/j.ijpharm.2016.03.021
Ultra-small lipid-dendrimer hybrid nanoparticles as a promising strategy for antibiotic delivery: In vitro and in silico studies.
Sandeep J. Sonawane (2016)
10.1021/ACS.MACROMOL.5B02231
Quaternized Chitosan/Poly(acrylic acid) Polyelectrolyte Complex Hydrogels with Tough, Self-Recovery, and Tunable Mechanical Properties
Jun You (2016)
10.1002/jps.23824
In vitro analysis of nanoparticulate hydroxyapatite/chitosan composites as potential drug delivery platforms for the sustained release of antibiotics in the treatment of osteomyelitis.
Vuk Uskoković (2014)
10.1016/J.SURFCOAT.2018.05.070
Electrophoretic deposition of vancomycin loaded halloysite nanotubes-chitosan nanocomposite coatings
Morteza Farrokhi-Rad (2018)
10.1007/978-1-4939-7686-7_9
Stability Considerations in the Life Cycle of Generic Products
Sanjay Bajaj (2018)
10.1016/j.ijbiomac.2012.06.038
Preparation of low molecular weight N-maleated chitosan-graft-PAMAM copolymer for enhanced DNA complexation.
K. Sarkar (2012)
10.1016/j.ejpb.2016.11.022
Pegylated oleic acid: A promising amphiphilic polymer for nano‐antibiotic delivery
Calvin A. Omolo (2017)
10.1186/s12951-016-0205-x
Simple surface functionalization of polymersomes using non-antibacterial peptide anchors
Ludwig Klermund (2016)
10.1080/10611860902718649
Amoxicillin, clarithromycin, and omeprazole based targeted nanoparticles for the treatment of H. pylori
Suman Ramteke (2009)
10.1016/j.bmcl.2010.01.159
Synthesis, antibacterial and antifungal activities of some carbazole derivatives.
Fei-fei Zhang (2010)
10.1517/17425247.2011.581655
New delivery systems to improve the bioavailability of resveratrol
A. Santos (2011)
10.1128/AAC.00833-10
In Vitro Spectrum of Activity of Finafloxacin, a Novel, pH-Activated Fluoroquinolone, under Standard and Acidic Conditions
W. Stubbings (2011)
10.1016/j.colsurfb.2017.07.049
pH-responsive chitosan nanoparticles from a novel twin-chain anionic amphiphile for controlled and targeted delivery of vancomycin.
Rahul S. Kalhapure (2017)
10.1016/j.colsurfb.2005.06.001
Modulation of surface charge, particle size and morphological properties of chitosan-TPP nanoparticles intended for gene delivery.
Quan Gan (2005)
10.1007/s12274-012-0275-5
Hollow iron oxide nanoparticles as multidrug resistant drug delivery and imaging vehicles
Ruijun Xing (2012)
10.1007/s11051-014-2479-y
Phosphatidylcholine nanovesicles coated with chitosan or chondroitin sulfate as novel devices for bacteriocin delivery
Indjara Mallmann da Silva (2014)
10.1128/JCM.02548-10
Rapid Differentiation of Methicillin-Resistant and Methicillin-Susceptible Staphylococcus aureus by Flow Cytometry after Brief Antibiotic Exposure
Nabin K Shrestha (2011)
10.1002/APP.38814
Formulation of pH‐responsive carboxymethyl chitosan and alginate beads for the oral delivery of insulin
Piyasi Mukhopadhyay (2013)
10.5681/apb.2012.007
Design of vancomycin RS-100 nanoparticles in order to increase the intestinal permeability.
Badir Delf Loveymi (2012)
10.1128/AAC.49.8.3435-3441.2005
Establishment of a Superficial Skin Infection Model in Mice by Using Staphylococcus aureus and Streptococcus pyogenes
Elisabeth Kugelberg (2005)
10.1002/jbm.a.36347
Synthesis and characterization of biogenic selenium nanoparticles with antimicrobial properties made by Staphylococcus aureus, methicillin-resistant Staphylococcus aureus (MRSA), Escherichia coli, and Pseudomonas aeruginosa.
David Medina Cruz (2018)
10.1128/JB.00393-13
Role of autofluorescence in flow cytometric analysis of Escherichia coli treated with bactericidal antibiotics.
Sabine Renggli (2013)
10.1016/J.PARTIC.2011.08.007
Lipid-polymer hybrid nanoparticles with rhamnolipid-triggered release capabilities as anti-biofilm drug delivery vehicles
Wean Sin Cheow (2012)
10.3390/ijms14022846
Monovalent Ions and Water Dipoles in Contact with Dipolar Zwitterionic Lipid Headgroups-Theory and MD Simulations
Aljaž Velikonja (2013)
10.3390/polym9070280
Vesicles from Amphiphilic Dumbbells and Janus Dendrimers: Bioinspired Self-Assembled Structures for Biomedical Applications
Soraya Taabache (2017)
10.1016/j.ijantimicag.2018.04.003
The impact of antibiotic prescription rates on the incidence of MRSA bloodstream infections: A county-level, US-wide analysis.
Nikolaos Andreatos (2018)
10.1016/j.ejmech.2017.08.039
Arylthiazole antibiotics targeting intracellular methicillin-resistant Staphylococcus aureus (MRSA) that interfere with bacterial cell wall synthesis.
I. Eid (2017)
10.1016/j.bios.2017.06.058
A novel multifunctional electrochemical platform for simultaneous detection, elimination, and inactivation of pathogenic bacteria based on the Vancomycin-functionalised AgNPs/3D-ZnO nanorod arrays.
Zhiqing Yang (2017)
10.1039/c4bm00306c
Assembling Mn:ZnSe quantum dots-siRNA nanoplexes for gene silencing in tumor cells.
Yucheng Wang (2015)
10.1016/j.ejps.2016.11.028
Spanish Broom (Spartium junceum L.) fibers impregnated with vancomycin‐loaded chitosan nanoparticles as new antibacterial wound dressing: Preparation, characterization and antibacterial activity
Teresa Cerchiara (2017)
10.1016/j.colsurfb.2016.04.054
PEGylated PLGA nanospheres optimized by design of experiments for ocular administration of dexibuprofen-in vitro, ex vivo and in vivo characterization.
E. Sánchez-López (2016)
10.1016/j.meegid.2013.04.030
Evolution of community- and healthcare-associated methicillin-resistant Staphylococcus aureus.
A. Uhlemann (2014)
10.1016/j.jgar.2018.05.001
Daptomycin and vancomycin heteroresistance revealed among CC5-SCCmecII MRSA clone and in vitro evaluation of treatment alternatives.
Jessica Baleiro Okado (2018)
10.3390/polym10030235
Chitosan Based Self-Assembled Nanoparticles in Drug Delivery
Javier Pérez Quiñones (2018)
10.1016/j.biomaterials.2013.01.005
In vitro antitumor activity of methotrexate via pH-sensitive chitosan nanoparticles.
Daniele Rubert Nogueira (2013)
10.3389/fmicb.2017.00580
Current Perspectives on Viable but Non-culturable State in Foodborne Pathogens
Xihong Zhao (2017)
10.1016/j.jiac.2018.03.004
Change in genotype of methicillin-resistant Staphylococcus aureus (MRSA) affects the antibiogram of hospital-acquired MRSA.
Dai Harada (2018)
10.1016/j.jconrel.2017.08.007
Particle engineering for intracellular delivery of vancomycin to methicillin‐resistant Staphylococcus aureus (MRSA)‐infected macrophages
Yihua Pei (2017)
10.1023/A:1018913921956
A New Bioerodible Polymer Insert for the Controlled Release of Metronidazole
Kimberly A. Gates (2004)
10.1016/j.ijpharm.2012.07.009
Antimicrobial properties of cyclodextrin-antiseptics-complexes determined by microplate laser nephelometry and ATP bioluminescence assay.
Susanne Finger (2012)
10.1021/bm800276d
Why is chitosan mucoadhesive?
Ioannis A Sogias (2008)
10.1086/651094
Excess costs and utilization associated with methicillin resistance for patients with Staphylococcus aureus infection.
Gregory A. Filice (2010)
10.1038/s41426-018-0038-9
Analysis of global prevalence of antibiotic resistance in Acinetobacter baumannii infections disclosed a faster increase in OECD countries
Ruiqiang Xie (2018)
10.1016/j.ijantimicag.2017.05.006
Recently approved antibacterials for methicillin-resistant Staphylococcus aureus (MRSA) and other Gram-positive pathogens: the shock of the new.
M. David (2017)
10.1021/nn800275r
Self-assembled lipid--polymer hybrid nanoparticles: a robust drug delivery platform.
L. Zhang (2008)
10.1016/J.JMMM.2008.05.023
Heat generation of aqueously dispersed CoFe2O4 nanoparticles as heating agents for magnetically activated drug delivery and hyperthermia
Deok-ryeong Kim (2008)
10.1126/science.284.5417.1143
Polymersomes: tough vesicles made from diblock copolymers.
Bohdana M. Discher (1999)
10.1002/cyto.a.22219
A flow cytometric method for viability assessment of Staphylococcus aureus and Burkholderia cepacia in mixed culture.
Marc Rüger (2012)
10.1016/j.colsurfb.2016.07.062
Improving solubility, stability, and cellular uptake of resveratrol by nanoencapsulation with chitosan and γ-poly (glutamic acid).
Young Ok Jeon (2016)
10.2174/138161211795049822
Self assembling polymers as polymersomes for drug delivery.
Jay Prakash Jain (2011)
10.1039/C6RA05574E
Chitosan-coated liposomes encapsulating curcumin: Study of lipid-polysaccharide interactions and nanovesicle behavior
Mahmoud Hasan (2016)
10.1081/BIO-120028669
Encapsulation of Enzymes in Liposomes: High Encapsulation Efficiency and Control of Substrate Permeability
Barnabé Chaize (2004)
10.1016/j.colsurfb.2016.05.027
pH-responsive zwitterionic polypeptide as a platform for anti-tumor drug delivery.
Na Liu (2016)
10.1016/j.micpath.2018.03.014
Antibacterial mechanism of artemisinin / beta-cyclodextrins against methicillin-resistant Staphylococcus aureus (MRSA).
L. Lin (2018)
10.3109/17435390.2014.930195
Towards understanding mechanisms governing cytotoxicity of metal oxides nanoparticles: Hints from nano-QSAR studies
A. Gajewicz (2015)
Some data provided by SemanticScholar